DAVID SHIN: Open Payments
NPI 1366112526 · FORT LEE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,182 in 128 payments from 16 companies in 2025. Trend: 2023 $1,312 · 2024 $1,883 · 2025 $2,182
Food & beverage: $1,980Education: $202
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 27 | $532 |
| LEO Pharma Inc. | 21 | $278 |
| ABBVIE INC. | 14 | $236 |
| PFIZER INC. | 15 | $221 |
| Incyte Corporation | 14 | $152 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $110 |
| Lilly USA, LLC | 5 | $95 |
| Arcutis Biotherapeutics, Inc. | 5 | $80 |
| UCB, Inc. | 4 | $73 |
Products named: DUPIXENT, ADBRY, CIBINQO, OPZELURA, RINVOQ, SKYRIZI, Zoryve, Bimzelx.
Industry payments across NJ — which companies pay providers there.
